Seelos Therapeutics Inc banner

Seelos Therapeutics Inc
NASDAQ:SEEL

Watchlist Manager
Seelos Therapeutics Inc Logo
Seelos Therapeutics Inc
NASDAQ:SEEL
Watchlist
Price: 0.39 USD -27.79%
Market Cap: $100k

Cash Flow Statement

Cash Flow Statement
Seelos Therapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Operating Cash Flow
Net Income
(6)
(6)
(22)
(25)
(32)
(34)
(19)
(15)
(13)
(9)
(7)
3
5
2
0
(8)
(7)
(5)
(3)
(38)
(40)
(42)
(51)
(21)
(22)
(23)
(19)
(33)
(39)
(45)
(66)
(61)
(73)
(82)
(74)
(73)
(81)
(51)
(38)
(27)
4
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Deffered Taxes
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Stock-Based Compensation
2
2
2
2
1
1
1
1
2
2
2
2
1
1
1
1
1
1
1
1
1
1
0
1
1
1
2
2
3
3
8
10
10
10
5
4
4
0
0
0
0
Other Non-Cash Items
(2)
(1)
5
6
7
6
(2)
(6)
(5)
(3)
(4)
(12)
(11)
(12)
(10)
2
1
0
0
26
25
25
25
(1)
1
2
3
6
8
8
18
17
18
19
9
13
29
5
2
(7)
(30)
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Interest Paid
0
0
0
0
0
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
Change in Working Capital
(1)
(1)
(1)
(5)
(3)
(2)
(2)
(2)
1
1
(1)
(1)
(2)
(1)
(1)
(1)
0
1
2
3
3
2
7
4
0
(1)
(5)
2
2
3
(1)
(11)
(11)
(3)
3
6
12
11
12
15
13
Cash from Operating Activities
(8)
N/A
(8)
+3%
(18)
-132%
(24)
-33%
(28)
-17%
(30)
-9%
(23)
+26%
(23)
-1%
(17)
+24%
(12)
+33%
(13)
-12%
(9)
+27%
(9)
+10%
(11)
-25%
(10)
+2%
(8)
+23%
(6)
+24%
(4)
+40%
(2)
+57%
(9)
-483%
(12)
-33%
(15)
-19%
(19)
-32%
(18)
+8%
(21)
-20%
(23)
-6%
(21)
+8%
(26)
-23%
(28)
-7%
(34)
-23%
(49)
-44%
(55)
-12%
(66)
-21%
(67)
-1%
(62)
+8%
(55)
+11%
(40)
+26%
(35)
+13%
(24)
+32%
(18)
+24%
(13)
+27%
Investing Cash Flow
Capital Expenditures
(1)
(1)
(1)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Items
1
1
1
1
0
0
0
0
0
0
0
12
12
12
12
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
0
N/A
(0)
N/A
0
N/A
0
+97%
(0)
N/A
(0)
+15%
(0)
-16%
(0)
+78%
0
N/A
0
+15%
0
+95%
12
+4 304%
12
+1%
12
+2%
12
+2%
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Financing Cash Flow
Net Issuance of Common Stock
2
5
6
15
15
12
11
10
10
14
14
5
11
10
10
11
6
3
0
19
20
28
30
19
17
15
15
46
112
105
126
86
20
21
1
11
11
15
19
12
13
Net Issuance of Debt
(2)
(2)
2
2
3
8
4
4
3
(3)
(3)
(9)
(9)
(8)
(7)
0
0
0
1
0
0
0
0
0
0
0
11
6
(3)
(3)
(14)
(8)
0
0
(2)
(3)
(5)
(7)
(8)
(8)
(6)
Other
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
0
(0)
0
0
0
0
Cash from Financing Activities
1
N/A
3
+520%
8
+135%
17
+120%
18
+5%
20
+12%
15
-24%
14
-12%
13
-8%
11
-10%
11
-3%
(5)
N/A
2
N/A
2
-18%
3
+62%
10
+288%
4
-58%
1
-66%
1
-2%
20
+1 401%
22
+6%
30
+36%
30
0%
19
-35%
18
-8%
15
-12%
26
+70%
52
+97%
109
+111%
103
-6%
112
+9%
78
-31%
20
-74%
21
+1%
(2)
N/A
7
N/A
5
-30%
7
+43%
11
+59%
5
-59%
8
+65%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Change in Cash
(7)
N/A
(5)
+39%
(10)
-122%
(6)
+37%
(10)
-58%
(10)
-3%
(8)
+27%
(9)
-23%
(5)
+49%
(0)
+96%
(2)
-823%
(3)
-75%
5
N/A
3
-44%
4
+49%
2
-45%
(2)
N/A
(2)
-31%
(0)
+89%
11
N/A
10
-15%
15
+57%
10
-32%
1
-86%
(4)
N/A
(7)
-87%
5
N/A
26
+381%
81
+213%
69
-15%
63
-8%
23
-63%
(46)
N/A
(46)
-1%
(63)
-36%
(48)
+25%
(35)
+26%
(28)
+21%
(13)
+55%
(14)
-8%
(6)
+59%
Free Cash Flow
Free Cash Flow
(9)
N/A
(9)
+2%
(19)
-113%
(24)
-31%
(28)
-16%
(31)
-9%
(23)
+25%
(23)
+0%
(18)
+23%
(12)
+33%
(13)
-11%
(10)
+27%
(9)
+10%
(11)
-25%
(10)
+2%
(8)
+23%
(6)
+24%
(4)
+40%
(2)
+57%
(9)
-483%
(12)
-33%
(15)
-19%
(19)
-32%
(18)
+8%
(21)
-20%
(23)
-6%
(21)
+8%
(26)
-23%
(28)
-7%
(34)
-23%
(49)
-44%
(55)
-12%
(66)
-21%
(67)
-1%
(62)
+8%
(55)
+11%
(40)
+26%
(35)
+13%
(24)
+32%
(18)
+24%
(13)
+27%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett